Analyst Reco. Bio-Rad Laboratories, Inc.

Equities

BIO

US0905722072

Real-time Estimate Cboe BZX Other stock markets 03:28:20 2024-04-25 pm EDT			5-day change	1st Jan Change
277.8 ^USD	-0.17%		-1.20%	-14.01%

Apr. 15	Zacks Investment Research Lowers Price Target on Bio-Rad Laboratories to $285 From $322	MT
Apr. 11	Oncocyte Corporation and Bio-Rad Laboratories, Inc. Partner on Global Launch of Transplant Assay	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zacks Investment Research Lowers Price Target on Bio-Rad Laboratories to $285 From $322	Apr. 15	MT
RBC Trims Price Target on Bio-Rad Laboratories to $474 From $480, Keeps Outperform Rating	Apr. 08	MT
Citigroup Downgrades Bio-Rad Laboratories to Neutral From Buy, Adjusts Price Target to $365 From $400	Apr. 03	MT
UBS Adjusts Bio-Rad Laboratories Price Target to $420 From $395, Maintains Buy Rating	Feb. 16	MT
RBC Trims Price Target on Bio-Rad Laboratories to $480 From $484, Keeps Outperform Rating	Feb. 16	MT
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom...	Jan. 03
UBS Initiates Coverage on Bio-Rad Laboratories With Buy Rating, $395 Price Target	Dec. 07	MT
RBC Cuts Price Target on Bio-Rad Laboratories to $482 From $513, Notes 'Near-Term Headwinds,' Keeps Outperform Rating	23-10-27	MT
ANALYST RECOMMENDATIONS : Amazon, Comcast, Intel, Merck, Roblox...	23-10-27
Wells Fargo Adjusts Price Target on Bio-Rad Laboratories to $525 From $550, Keeps Overweight Rating	23-08-07	MT
Wells Fargo Lowers Price Target on Bio-Rad Laboratories to $525 From $550, Maintains Overweight Rating	23-08-07	MT
Credit Suisse Adjusts Bio-Rad Laboratories' Price Target to $550 From $580, Keeps Outperform Rating	23-08-04	MT
RBC Raises Price Target on Bio-Rad Laboratories to $524 From $522, Maintains Outperform Rating	23-08-04	MT
RBC Cuts Bio-Rad Laboratories' Price Target to $522 From $536, Keeps Outperform Rating	23-07-17	MT
Wells Fargo Initiates Bio-Rad Laboratories With Overweight Rating, $550 Price Target	23-06-16	MT
ANALYST RECOMMENDATIONS : Adobe, Wells Fargo, American Express...	23-06-16
RBC Boosts Price Target on Bio-Rad Laboratories to $536 From $531, Maintains Outperform Rating	23-05-15	MT
Citigroup Adjusts Bio-Rad Laboratories' Price Target to $525 From $550, Keeps Buy Rating	23-05-08	MT
RBC Cuts Price Target on Bio-Rad Laboratories to $531 From $582 After Guidance Cut But Sees Buying Opportunity After Stock Drop; Outperform Kept	23-05-08	MT
Credit Suisse Cuts Bio-Rad Laboratories' PT to $580 From $680 After Lower-Than-Expected Q1 Results, Keeps Outperform Rating	23-05-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Bio-Rad Laboratories, Inc.

Equities

BIO

US0905722072

Analyst Reco.

Filters